A Systematic review of the Primary Therapeutic interventions used in COVID-19 patients who were reinfected

On March 11th, 2020, COVID-19 was declared a global pandemic. Since then, data has been recorded, correlated and reviewed in an effort to better understand how to combat the spread and lower the morbidity of the disease. In this pursuit, many studies have linked the presence of comorbidities, diabetes among those, with a higher mortality rate. To further this line of thought, this review was meant to investigate the factors affecting this poorer prognosis and the risk of reinfection among this population.